VERSEON CORP has a total of 108 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, Australia and Singapore. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are HEPAREGENIX GMBH, APOTEX TECH INC and UNIV CHANG GUNG SCIENCE & TECHNOLOGY.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 18 | |
#2 | Australia | 14 | |
#3 | Singapore | 9 | |
#4 | China | 8 | |
#5 | Israel | 8 | |
#6 | Japan | 7 | |
#7 | Republic of Korea | 7 | |
#8 | Canada | 6 | |
#9 | Brazil | 5 | |
#10 | Mexico | 5 | |
#11 | EPO (European Patent Office) | 4 | |
#12 | Hong Kong | 4 | |
#13 | New Zealand | 4 | |
#14 | WIPO (World Intellectual Property Organization) | 4 | |
#15 | South Africa | 4 | |
#16 | Hungary | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Short Kevin Michael | 85 |
#2 | Pham Son Minh | 74 |
#3 | Williams David Charles | 63 |
#4 | Kita David Ben | 47 |
#5 | Datta Somalee | 24 |
#6 | Estiarte-Martinez Maria De Los Angeles | 21 |
#7 | Kevin Michael Short | 13 |
#8 | Shiau Timothy Philip | 12 |
#9 | Son Minh Pham | 7 |
#10 | David Ben Kita | 6 |
Publication | Filing date | Title |
---|---|---|
WO2020014669A1 | Thrombin inhibitors, formulations, and uses thereof | |
US2017326125A1 | Multisubstituted aromatic compounds as inhibitors of thrombin | |
WO2016138532A1 | Substituted pyrazole compounds as serine protease inhibitors | |
US2016251341A1 | Substituted triazole compounds as serine protease inhibitors | |
CN106687445A | Pyrazolyl-substituted pyridone compounds as serine protease inhibitors | |
US2016046585A1 | Halogenopyrazoles as inhibitors of thrombin | |
US2016024047A1 | Multisubstituted aromatic compounds as serine protease inhibitors | |
WO2013049591A2 | Dual inhibitor compounds and methods of use thereof | |
NZ700332A | Multisubstituted aromatic compounds as inhibitors of thrombin |